Invitation for Applications: The 2026 ATTR Research Forum Supporting Early-Career Scientists

2026 ATTR Early-Career Research Forum: Call for Abstracts

The ATTR Early-Career Research Forum is set to return for its third annual installment, promoting cutting-edge research in the realm of ATTR amyloidosis. This event, orchestrated by Cornerstone Medical Education, receives sponsorship from prestigious pharmaceutical companies: AstraZeneca and Ionis Pharmaceuticals.

As part of the forum, early-career physician-scientists are strongly encouraged to submit their research abstracts by the deadline of October 2, 2026. This initiative is designed not only to recognize their valuable contributions to the field but also to foster a platform for collaboration and innovative thinking among peers and leading experts.

The most promising four investigators will be selected through a thorough blinded review of the submitted abstracts and invited to showcase their work during a live virtual forum scheduled for October 29, 2026, from 5:00 to 7:00 PM ET. During this critical presentation, top-rated researchers will have the chance to engage directly with established figures in the field of ATTR, gaining invaluable feedback and insights.

Among the highlights of this forum is the Wiesman Award for Excellence in Early-Career ATTR Research, which consists of two $100,000 grants aimed at supporting pioneering projects. Named in honor of Dr. Janice Wiesman, a revered clinician-researcher in the field, the award seeks to catalyze progress in ATTR diagnostic and treatment strategies. As emphasized by Dr. Evangelos Oikonomou from Yale University, these awards represent a significant opportunity, providing essential funds and facilitating connections with industry leaders that can help bring high-risk, transformative ideas into fruition.

Early-career investigators of ATTR amyloidosis are pivotal in enhancing understanding and improving treatment methodologies for this complex condition. Their fresh perspectives and groundbreaking research are essential to pushing boundaries in medical science, especially as advancements in diagnosis and treatment are evolving at a rapid pace. The support rendered through initiatives like the ATTR Research Forum is crucial in nurturing and encouraging the next generation of scientists and physicians dedicated to battling ATTR amyloidosis.

In an environment where innovation can lead to life-altering changes for patients, this call for abstracts serves as a beacon for aspiring researchers in the medical field. It offers them a unique platform to present their findings, engage in critical discussions, and compete for substantial support to drive their work forward.

For aspiring applicants, this is not just an opportunity for funding; it's a chance to be part of a community that strives to improve patient outcomes through dedicated, high-quality research. As the deadline approaches, those interested are urged to prepare their submissions thoughtfully and aim for a spotlight that could pave the way for their future in science.

For further information regarding the submission process and additional specifics about the forum, please visit Cornerstone Medical Education or contact their dedicated support team.